How do we do it?

Strategic pipeline planning is critical. It provides a clear vision for your company. In fact, this is also very important for multinational companies when they decide to license out products.

With close to 100K molecules in development, selecting a therapeutic class helps narrow down your options. This also improves synergies with the portfolio which has a positive impact on financials.

The objective is to identify a handful of innovative products that will meet unmet medical needs and fit the chosen local market dynamics (e.g. competition, pricing, and access).